Organogenesis Holdings Inc.ORGO

時価総額
$3.8億
PER
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
Net income---65-40189516
Depreciation--33466
Amortization of intangible assets--46455
Amortization of operating lease right-of-use assets-----67
Non-cash interest expense--30000
Deferred interest expense---1211
Deferred rent expense----1--
Gain on settlement of deferred acquisition consideration----2--
Deferred tax expense (benefit)--000-322
Loss on disposal of property and equipment---1-0-0-1-4
Provision recorded for doubtful accounts--10232
Adjustment for excess and obsolete inventories-----3-12-10
Stock-based compensation--11247
Loss on extinguishment of debt---2-2--2-
Change in fair value of Earnout liability----0-4-
Change In Fair Value Of Warrants--0----
Accounts receivable--7519299
Inventory--511799
Prepaid expenses and other current assets--11100
Operating leases-----67
Accounts payable---05-143
Accrued expenses and other current liabilities--0319-12
Other liabilities--0-1-0-60
Net cash provided by operating activities--586,604-61-3476225
Purchases of property and equipment--26213134
Cash paid for business acquisition----6--
Acquisition of intangible asset---0---
Net cash used in investing activities-310,000,000--2-6-25-31-34
Line of credit repayments, net--97-23-10-
Proceeds from (Repayments of) Secured Debt------60-
Proceeds from Issuance of Senior Long-Term Debt----1073-
Term loan repayments under the 2021 Credit Agreement-----13
Proceeds from equity financing304--5065--
Payment of equity issuance costs348,761427,578036--
Repayment of notes payable--018---
Principal repayments of capital lease obligations---1230
Redemption of redeemable common stock placed into treasury---7---
Proceeds from Stock Options Exercised--00322
Proceeds from Warrant Exercises---1---
Payments of withholding taxes in connection with RSUs vesting-----11
Payments of deferred acquisition consideration----401
Payment to extinguish debt-----2-
Net cash provided by (used in) financing activities--327,578827942-1-2
Change in cash, cash equivalents and restricted cash--19392430-11
Cash paid for interest-----63
Income Taxes Paid--00011
Reimbursement of offering expenses included in prepaid expenses and other current assets----1--
Fair value of shares issued for business acquisition----8--
Deferred Acquisition Consideration And Earnout Liability For Business Acquisition----5-1
Deemed Dividends To Warrant Holders---1---
Equity issuance costs included in accounts payable---1---
Capital Expenditures Incurred but Not yet Paid---4242
Noncash or Part Noncash Acquisition, Intangible Assets Acquired---1---
Right-of-use assets obtained through lease obligations-----541